Efficacy of ICU-VTE Scale in ICU Patients

NCT05487066 | Completed

• 1 other identifier: WHZXKYL2022-117
• Study Type: observational
• Target: 269
• Locations: 1 country
• Sites: 1

Brief Summary

Venous thromboembolism (VTE) is a common cause of morbidity and mortality among critically ill patients. No uniform standard model of VTE risk for critically ill patients was formatted by now. In 2020, Viarasilpa et al. developed the ICU⁃VTE rating table, mainly for ICU patients. However, it lacks validation. We examined and compared how well the ICU-VTE score predict and stratify VTE risk in comprehensive ICU patients.

Conditions

Venous Thromboembolism

Keywords

Venous thromboembolism; Deep vein thrombosis; ICU; Critically ill

Outcome Measures

Primary Outcomes (1)

• incidence of VTE

  inhospital venous thromboembolism occurrence

  28-day

Secondary Outcomes (1)

• all-cause mortality

  28-day

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Inpatient in intensive care unit department of Wuhan Central Hospital

You may qualify if:

• patients age greater than or equal to 18 years;
• Patients or their family members agreed to the study and signed informed consent.

You may not qualify if:

• Patients admitted to ICU with VTE diagnosis or diagnosed with VTE within 24 hours of admission to ICU;
• Use the therapeutic dose of anticoagulation before admission to ICU or within 24 hours in ICU;
• Expected ICU stay of less than 48 hours;
• Patients cannot obtain imaging data to confirm the presence of VTE during ICU admission

Sponsors & Collaborators

• Lijuan Zhang: lead

Study Sites (1)

The Central Hospital of Wuhan

Wuhan, Hubei, 430014, China

Location

MeSH Terms

Conditions

Venous Thromboembolism; Venous Thrombosis; Critical Illness

Condition Hierarchy (Ancestors)

Thromboembolism; Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases; Thrombosis; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Juan Li Zhang, Master

  Intensive Care Unit, the Central Hospital of Wuhan

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: physician

Study Record Dates

• First Submitted: July 26, 2022
• First Posted: August 4, 2022
• Study Start: May 1, 2022
• Primary Completion: December 10, 2023
• Study Completion: December 10, 2023
• Last Updated: May 8, 2024

Record last verified: 2024-05

Locations

CN (1)